Skip to main content
SpringerLink
Log in

Radical Retropubic Prostatectomy: The USC Experience

  • Chapter
Carcinoma of the Prostate

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

  • 84 Accesses

Abstract

Adenocarcinoma of the prostate is currently the most common malignancy and second leading cause of death from cancer in men in the United States (Wingo et al. 1995). It has been estimated that 244 000 new cases of prostate cancer will be diagnosed in the United States in 1995, resulting in 40 400 prostate cancer deaths during the same period (Wingo et al. 1995). This estimate represents a 100% increase in new cases of prostate cancer when compared with 1991 (Boring et al. 1991). The discovery and subsequent routine use of serum prostate-specific antigen (PSA) is the most important factor leading to this dramatic increase in prostate cancer detection. While controversy still exists in the literature regarding the benefits of routine screening for prostate cancer, it is becoming standard practice amongst physicians to screen men over 50 years of age for prostate cancer on a yearly basis using both digital rectal examination (DRE) and serum PSA.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Anscher MS, Prosnitz LR (1987) Postoperative radiotherapy for patients with carcinoma of the prostate undergoing radical prostatectomy with positive surgical margins, seminal vesicle involvement and/or penetration through the capsule. J Urol 138:1407–1412

    PubMed  CAS  Google Scholar 

  • Boring CC, Squires TS, Tong T (1991) Cancer statistics, 1991. CA Cancer J Clin 41:19–36

    Article  PubMed  CAS  Google Scholar 

  • Catalona WJ, Smith DS, Ratliff TL, Basler JW (1993) Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 270:948–954

    Article  PubMed  CAS  Google Scholar 

  • deKernion JB, Neuwirth H, Stein A, Dorey F, Stenzl A, Hannah J, Blyth B (1990) Prognosis of patients with stage D1 prostate carcinoma following radical prostatectomy with and without early endocrine therapy. J Urol 144:700–703

    PubMed  CAS  Google Scholar 

  • Epstein JI, Carmichael MJ, Pizov G, Walsh PC (1993) Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup. J Urol 150:135–141

    PubMed  CAS  Google Scholar 

  • Freeman JA, Lieskovsky G, Cook DW, Petrovich Z, Chen SC, Groshen S, Skinner DG (1993) Radical retropubic prostatectomy and postoperative adjuvant radiation for pathologic stage C (PCNO) prostate cancer from 1976 to 1989: intermediate findings. J Urol 149:1029–1034

    PubMed  CAS  Google Scholar 

  • Freeman JA, Lieskovsky G, Grossfeld GD et al. (1994) Adjuvant radiation, chemotherapy, and androgen deprivation therapy for pathologic stage D1 adenocarcinoma of the prostate. Urology 44:719–725

    Article  PubMed  CAS  Google Scholar 

  • Gaynor JJ, Feuer EJ, Tan CC et al. (1993) On the use of cause-specific failure and conditional failure probabilities: examples from clinical oncology data. J Am Stat Assoc 88:400–409

    Article  Google Scholar 

  • Gibbons RP, Cole BS, Richardson RG et al. (1986) Adjuvant radiotherapy following radical prostatectomy: results and complications. J Urol 135:65–68

    PubMed  CAS  Google Scholar 

  • Hudson MA, Catalona WJ (1990) Effect of adjuvant radiation therapy on prostate specific antigen following radical prostatectomy. J Urol 143:1174–1177

    PubMed  CAS  Google Scholar 

  • Johansson JE, Andersson SO, Krusemo UB, Adami HO, Bergstrom R, Kraaz W (1989) Natural history of localised prostatic cancer: a population-based study in 223 untreated patients. Lancet 8642:799–803

    Article  Google Scholar 

  • Johansson JE, Adami HO, Andersson SO, Bergstrom R, Holmberg L, Krusemo UB (1992) High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA 267:2191–2196

    Article  PubMed  CAS  Google Scholar 

  • Koch MO, Smith JA, Hodge EM, Brandell RA (1994) Prospective development of a cost-efficient program for radical retropubic prostatectomy. Urology 44:311–318

    Article  PubMed  CAS  Google Scholar 

  • Lange PH, Lightner DJ, Medini E, Reddy PK, Vessella RL (1990) The effect of radiation therapy after radical prostatectomy in patients with elevated prostate specific antigen levels. J Urol 144:927–933

    PubMed  CAS  Google Scholar 

  • Lieskovsky G (1988) Technique of radical retropubic prostatectomy (Campbell’s Procedure) with limited pelvic lymph node dissection. In: Skinner DG, Lieskovsky G (eds) Diagnosis and management of genitourinary cancer. Saunders, Philadelphia, p 735

    Google Scholar 

  • Litwiller SE, Djavan B, Klopukh BV, Richier JC, Roehrborn CG (1995) Radical retropubic prostatectomy for localized carcinoma of the prostate in a large metropolitan hospital: changing trends over a 10-year period (1984–1994). Urology 45:813–822

    Article  PubMed  CAS  Google Scholar 

  • Mettlin C, Murphy GP, Menck H (1994) Trends in treatment of localized prostate cancer by radical prostatectomy: observations from the Commission on Cancer National Cancer Database, 1985–1990. Urology 43:488–492

    Article  PubMed  CAS  Google Scholar 

  • Miller RG (1981) Survival analysis. John Wiley, New York

    Google Scholar 

  • O’Donnell PD, Finan BF (1989) Continence following nerve- sparing radical prostatectomy. J Urol 142:1227–1229

    PubMed  Google Scholar 

  • Oesterling JE, Brendler CB, Epstein JI, Kimball AW, Walsh PC (1987) Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate. J Urol 138:92–98

    PubMed  CAS  Google Scholar 

  • Oesterling JE, Chan DW, Epstein JI et al. (1988) Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol 139:766–772

    PubMed  CAS  Google Scholar 

  • Partin AW, Yoo J, Carter HB, Pearson JD, Chan DW, Epstein JI, Walsh PC (1993) The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 150:110–114

    PubMed  CAS  Google Scholar 

  • Paulson DF, Lin GH, Hinshaw W, Stephani S, The UroOncology Research Group (1982) Radical surgery versus radiotherapy for adenocarcinoma of the prostate. J Urol 128:502–504

    PubMed  CAS  Google Scholar 

  • Paulson DF, Moul JW, Walther PJ (1990) Radical prostatectomy for clinical stage T1–2NOMO prostatic adenocarcinoma: long-term results. J Urol 144:1180–1184

    PubMed  CAS  Google Scholar 

  • Quinlan DM, Epstein JI, Carter BS, Walsh PC (1991) Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles. J Urol 145:998–1002

    PubMed  CAS  Google Scholar 

  • Smith JA, Middleton RG (1987) Clinical management of pros- tatic cancer. Year Book Medical Publishers, Chicago

    Google Scholar 

  • Stein A, deKernion JB, Dorey F, Smith RB (1992a) Adjuvant radiotherapy in patients post-radical prostatectomy with tumor extending through capsule or positive seminal vesicles. Urology 39:59–62

    Article  CAS  Google Scholar 

  • Stein A, deKernion JB, Smith RB, Dorey F, Patel H (1992b) Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer. J Urol 147:942–946

    CAS  Google Scholar 

  • Steinberg GD, Epstein JI, Piantadosi S, Walsh PC (1990) Management of stage D1 adenocarcinoma of the prostate: the Johns Hopkins experience 1974 to 1987. J Urol 144:1425–1432

    PubMed  CAS  Google Scholar 

  • Walsh PC (1988) Technique of radical retropubic prostatectomy with preservation of sexual function - an anatomic approach. In: Skinner DG, Lieskovsky G (eds) Diagnosis and management of genitourinary cancer. Saunders, Philadelphia, p 753

    Google Scholar 

  • Walsh PC (1990) Radical prostatectomy in locally confined prostatic carcinoma. In: Schroder FH (ed) EORTC genitourinary group monograph 8: treatment of prostatic cancer - facts and controversies. Wiley-Liss, New York, p 199

    Google Scholar 

  • Walsh PC, Lepor H (1987) The role of radical prostatectomy in the management of prostatic cancer. Cancer 60:526–537

    Article  PubMed  CAS  Google Scholar 

  • Wingo PA, Tong T, Bolden S (1995) Cancer statistics, 1995. CA Cancer J Clin 45:8–30

    Article  PubMed  CAS  Google Scholar 

  • Yamada AH, Lieskovsky G, Petrovich Z, Chen SC, Groshen S, Skinner DG (1994) Results of Radical prostatectomy and adjuvant therapy in the management of locally advanced, clinical stage TC, prostate cancer. Am J Clin Oncol 17:277–285

    Article  PubMed  CAS  Google Scholar 

  • Zietman AL, Coen JJ, Shipley WU, Althausen AF (1993) Adjuvant irradiation after radical prostatectomy for adenocarcinoma of the prostate: analysis of freedom from PSA failure. Urology 42:292–299

    Article  PubMed  CAS  Google Scholar 

  • Zincke H (1989) Extended experience with surgical treatment of stage D1 adenocarcinoma of prostate: significant influences of immediate adjuvant hormonal treatment (orchiectomy) on outcome. Urology (Suppl) 33:27–36

    Article  PubMed  CAS  Google Scholar 

  • Zincke H (1990) Combined surgery and immediate adjuvant hormonal treatment for stage D1 adenocarcinoma of the prostate: Mayo Clinic experience. Semin Urol 8:175–183

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Southern California School of Medicine, 2025 Zonal Avenue, GH5900, Los Angeles, CA, 90033, USA

    G. D. Grossfeld MD (Chief Resident in Urology) & G. Lieskovsky MD (Professor of Urology and Radiation Oncology)

  2. Division of Urology, University of North Carolina, Burnett-Womack Building CB#7235, Chapel Hill, NC, 27599, USA

    J. A. Freeman MD (Assistant Professor of Urology)

  3. Chung-Shan Medical and Dental School, School of Public Health, 113 Ta-Ching Street, Section 2, Taichung, Taiwan, 402

    S.-C. Chen PhD

  4. Department of Radiation Oncology, University of Southern California School of Medicine, 1441 Eastlake Avenue, Los Angeles, CA, 90033, USA

    Z. Petrovich MD (Professor of Radiation Oncology and Urology, Chairman)

  5. Department of Urology, University of Southern California School of Medicine, 2025 Zonal Avenue, GH5900, Los Angeles, CA, 90033, USA

    D. G. Skinner MD (Professor and Chairman)

Authors
  1. G. D. Grossfeld MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Lieskovsky MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. A. Freeman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S.-C. Chen PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Z. Petrovich MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. G. Skinner MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Southern California School of Medicine, 1441 Eastlake Avenue, Los Angeles, CA, 90033, USA

    Zbigniew Petrovich MD (Professor, Department of Radiation Oncology and Urology, Chairman, Department of Radiation Oncology) (Professor, Department of Radiation Oncology and Urology, Chairman, Department of Radiation Oncology)

  2. Department of Urology, St. Pieter’s Hospital, University of Leuven, Brusselsestraat 69, B-3000, Leuven, Belgium

    Luc Baert MD

  3. Department of Radiation Oncology and Nuclear Medicine, Medical College of Pennsylvania and Hahnemann University, 230 N. Broad Street, Philadelphia, PA, 1902-1192, USA

    Luther W. Brady MD (Professor and Chairman) (Professor and Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Grossfeld, G.D., Lieskovsky, G., Freeman, J.A., Chen, SC., Petrovich, Z., Skinner, D.G. (1996). Radical Retropubic Prostatectomy: The USC Experience. In: Petrovich, Z., Baert, L., Brady, L.W. (eds) Carcinoma of the Prostate. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60956-5_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60956-5_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64627-0

  • Online ISBN: 978-3-642-60956-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation